Meeder Asset Management’s Avidity Biosciences RNAM Stock Holding History

Meeder Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48	Closed	-$3.46K	–	996
2025 Q4	$3.46K	Buy	48 +4	+9%	+$258	﹤0.01%	834
2025 Q3	$1.92K	Sell	44 -23	-34%	-$930	﹤0.01%	782
2025 Q2	$1.9K	Buy	+67	New	+$2K	﹤0.01%	817
2025 Q1	–	Sell	-55	Closed	-$1.6K	–	1025
2024 Q4	$1.6K	Buy	55 +1	+2%	+$42	﹤0.01%	891
2024 Q3	$2.48K	Buy	+54	New	+$2.34K	﹤0.01%	819

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Meeder Asset Management's RNAM Position: Q1 2026 in Review

Meeder Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 48 shares — an estimated $3.46K sold.

Meeder Asset Management first reported a position in RNAM in Q3 2024 and held it in 5 quarters. The position peaked at $3.46K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Meeder Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Meeder Asset Management sold 48 Avidity Biosciences shares in Q1 2026, an estimated $3.46K.
Meeder Asset Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 5 quarters.
Meeder Asset Management's Avidity Biosciences position peaked at $3.46K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.